Chinese study: Novel coronavirus has evolved into two major subtypes
Updated 15:54, 07-Mar-2020
Cao Qingqing

Translating...

Content is automatically generated by Microsoft Azure Translator Text API. CGTN is not responsible for any of the translations.

The novel coronavirus, which has caused the widespread epidemic COVID-19 since late December 2019, has evolved into two major subtypes, a Chinese study has revealed. 

To detect whether the virus, named SARS-CoV-2, has mutated, a group of Chinese researchers conducted population genetic analyses of 103 publicly available genomes of the virus, and found that it had evolved into two major subtypes (designated L and S), with differentiated infectivity. 

The study, titled On the origin and continuing evolution of SARS-CoV-2, was published on the National Science Review of the Chinese Academy of Sciences (CAS) on Tuesday (March 3).  

The understanding of different subtypes of SARS-CoV-2 will help promote differentiated and more efficient treatment of the disease. And the study also provides novel insights into tracing the intermediate natural host of SARS-CoV-2, according to the authors.  

Below are the major findings of the study: 

The S type was ancestral, and the L type evolved from S type. 

The L type (about 70 percent) was more prevalent than the S type (about 30 percent).  

Human intervention may have placed more severe selective pressure on the L type, which might be more aggressive and spread more quickly than the S type.

What remains unclear about the mutations :

It is currently unclear whether L type evolved from the S type in humans or in the intermediate hosts. 

It is also unclear whether the L type is more virulent than the S type. 

Whether and how these mutations affect the transmission and pathogenesis of SARS-CoV-2 remain to be discovered.  

Besides, the data examined in this study are still very limited, the authors wrote, adding that follow-up analyses of a larger set of data are needed to have a better understanding of the evolution and epidemiology of SARS-CoV-2.